Comparing the outcomes of noninferiority (NI) and superiority phase III trials.

被引：0
|
作者：
Saad, Everardo D.
Buyse, Marc E.
机构：
[1] Dendrix Res, Sao Paulo, Brazil
[2] Int Inst Drug Dev, Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13055
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Trends in the design and interpretation of metastatic colorectal cancer phase III clinical trials.
    Parimi, Sunil
    Raissouni, Soundouss
    Lin, Yongtao
    Monzon, Jose Gerard
    Tang, Patricia A.
    Tam, Vincent Channing
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [22] Effect size (ES) meta-analysis approach to noninferiority clinical trials.
    Spyker, D
    Munera, C
    Davalloo, S
    Wright, C
    Fitzmartin, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P33 - P33
  • [23] Systematic review of time to response (TTR) in phase III metastatic cancer trials.
    Butler, Taylor
    Lopez-Trigo, Paula
    Butler, Thomas
    PHARMACOTHERAPY, 2015, 35 (05): : E92 - E93
  • [24] Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials
    Tsong, Yi
    Zhang, Joanne
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (02) : 247 - 257
  • [25] Comparative Effectiveness Clinical Trials in Psychiatry: Superiority, Noninferiority, and the Role of Active Comparators
    Leon, Andrew C.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (10) : 1344 - 1349
  • [26] Unifying Design and Analysis for Superiority and Noninferiority Trials With Appropriate End Point Reply
    Acuna, Sergio A.
    Dossa, Fahima
    Baxter, Nancy N.
    JAMA SURGERY, 2019, 154 (05) : 467 - 468
  • [27] Outcomes of patients with advanced cancer and KRAS mutation in phase I clinical trials.
    Tsimberidou, Apostolia Maria
    Said, Rabih
    Falchook, Gerald Steven
    Janku, Filip
    Naing, Aung
    Zinner, Ralph
    Blumenschein, George R.
    Fu, Siqing
    Hong, David S.
    Piha-Paul, Sarina Anne
    Wheier, Jennifer J.
    Ye, Yang
    Hess, Kenneth R.
    Palmer, Gary A.
    Wolff, Robert A.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Predicting outcomes in patients with advanced malignancies treated on Phase 1 clinical trials.
    Wong, Kit Man
    Gao, Dexiang
    McCoy, Heather
    Brock, Amanda
    Powell, Rebecca W.
    O'Bryant, Cindy L.
    Camidge, D. Ross
    Gore, Lia
    Jimeno, Antonio
    Diamond, Jennifer Robinson
    Messersmith, Wells A.
    Eckhardt, S. Gail
    Leong, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Clinical outcomes of patients with solid tumor enrolled in phase 1 clinical trials.
    Denson, Aaron Cleveland
    Juan, TzuHua
    Lee, Jae K.
    Kim, Richard D.
    Sullivan, Daniel
    Wapinsly, Georgine
    Bertles, Barbara
    Mahipal, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] A Note on Comparing Two Binomial Proportions in Confirmatory Noninferiority Trials
    Zhengqing Li
    Christy Chuang-Stein
    Drug information journal : DIJ / Drug Information Association, 2006, 40 (2): : 203 - 208
12345